Calamos Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,381	Closed	-$950K	–	987
2023 Q2	$950K	Buy	4,381 +2,929	+202%	+$635K	﹤0.01%	686
2023 Q1	$264K	Buy	+1,452	New	+$264K	﹤0.01%	849